87 results
Page 2 of 5
8-K
EX-10.1
rryawo0eml p507j
5 Nov 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
l5cora
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.2
p5ixn67g8f9ba
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
6gv2w8ojpynijr0zfs
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.1
0bcv2sw3z8ru1de 6rmf
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.2
52g6o9l
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K
EX-99.1
r1o8tobe1t4lzgl xk
29 Sep 20
Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer
4:05pm
8-K
EX-10.1
moozo0 0m5i3l
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
oe7l22idjkg3i
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
7t60bt odz1bcup8
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
z3vr w3fntz
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
2nwj74ff5 yfqlty6k
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm